Omeros Corporation
Nasdaq OMER · Seattle, WA
Works in Dermatology · Hematology · Immunology · Ophthalmology · Renal & urogenital · Women's health
Omeros Corporation is a clinical trial sponsor based in Seattle, WA, listed as Nasdaq OMER. It has 3 active clinical trials with 63 planned participants, across 6 therapeutic areas. Since 2021 it has completed 4 trials and stopped 3 early.
Trial track record · since 2021
Financials · Nasdaq OMER
Fundraising
Pipeline · 3 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
1 approved drug application with a product on the market.
Questions about Omeros Corporation
Omeros Corporation is lead sponsor of 3 active clinical trials on ClinicalTrials.gov, with 63 planned participants, in Dermatology, Hematology, Immunology, Ophthalmology and other areas. Since 2021 it has completed 4 trials and stopped 3 early.
Omeros Corporation is based in Seattle, WA and is listed as Nasdaq OMER. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Omeros Corporation; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-07-16.
Approve Suite is not affiliated with Omeros Corporation.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.